世界の高活性原薬（HPAPI）受託製造市場（2023年版）：製剤別（注射剤、経口固形剤、ローション、その他）、最終用途別、地域別、国別の分析：市場インサイトと予測（2019-2029年）

Global High Potency API (HPAPI) Contract Manufacturing Market(2023 Edition): Analysis By Formulation (Injectables, Oral Solids, Lotions, Others), End Use, By Region, By Country: Market Insights and Forecast (2019-2029)

エグゼクティブ・サマリー Azoth Analytics社はこのたび、「高活性原薬受託製造市場（2023年版）」と題する調査報告書を発表しました。この調査報告書では、世界の高活性原薬受託製造業界について、2019-2022... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Azoth Analytics アーゾスアナリティクス	2023年9月1日	US$2,450 シングルユーザライセンスライセンス・価格情報注文方法はこちら	200	英語

サマリー

エグゼクティブ・サマリー

Azoth Analytics社はこのたび、「高活性原薬受託製造市場（2023年版）」と題する調査報告書を発表しました。この調査報告書では、世界の高活性原薬受託製造業界について、2019-2022年の過去期間、2023年の推定期間、2024-2029年の予測期間について、世界、地域、国レベルでの製剤別（注射剤、経口固形剤、ローション、その他の製剤）、最終用途別（がん、抗糖尿病薬、自己免疫薬、その他）の市場区分の観点から完全な分析を提供しています。

調査レポートは、地域（米州、欧州、APAC、中東アフリカ）と10カ国（米国、カナダ、英国、ドイツ、スイス、ベルギー、スペイン、中国、インド、日本）の詳細な分析をカバーしている。さらに、この調査レポートは、市場規模、年間成長＆潜在力分析、市場プレイヤーの競合調査、投資機会、需要予測などのデータを提示しています。また、成長指標、阻害要因、需給リスク、その他の重要統計、市場の進化に関連する現在および将来の市場動向の完全評価も行っています。

世界の高活性原薬受託製造市場は、2022年の108億9,000万米ドルから2029年末までに211億2,000万米ドルを創出すると予測される。予測期間である2024年から2029年にかけて、世界の高活性原薬受託製造市場は10.2%のCAGRで成長すると予測されます。

HPAPIの受託製造は、強力で複雑な治療用化合物の製造を専門とする製薬業界のダイナミックなセクターである。HPAPIは強力で治療量が少ないことが特徴であり、安全性と有効性の両方を保証するために、しばしば慎重な取り扱いと製造手順が要求される。

特に発展途上国における医療費の増加は、製品ポートフォリオの拡大を目指す現地の製薬会社におけるHPAPI需要の高まりによる受託製造セクター拡大の主要因となっている。政府と民間部門は研究開発に投資を行い、先端治療へのアクセスを改善している。

さらに、中堅規模の製薬会社の増加も市場の成長を後押ししている。受託製造により、大規模な設備投資を行うことなく、高力価の医薬品を製造することが可能になるからだ。

レポートの範囲

- このレポートは高活性原薬受託製造市場を金額（億米ドル）別に分析しています。

- 2019-2022年の過去期間、2023年の推定期間、2024-2029年の予測期間における高活性原薬受託製造市場の分析を掲載しています。

- 高活性原薬受託製造市場を製剤別（注射剤、経口固形剤、ローションその他の製剤）に分析しています。

- 高活性原薬受託製造市場をエンドユーザー別（がん、抗糖尿病、自己免疫、その他）に分析したレポートです。

- 本レポートの主要な洞察は、SWOTおよびポーターのファイブフォース分析の枠組みを通じて提示されている。また、市場の魅力を地域別、サービス別、操業形態別、エンドユーザー別に紹介しています。

- また、業界の主な機会、動向、促進要因、課題についても分析しています。

- レポートでは、競合の動向、戦略、M&A、新製品開発などを追跡しています。本レポートで分析している企業は、ロンザ、キャタレント、ピラマル・ファーマ・ソリューションズ、ファイザー・センターワン、ジェンテック・ファーマシューティカル・グループ、アッヴィ・コントラクト・マニュファクチャリング、コーデン・ファーマ・インターナショナル、キュリア・グローバル、メルク・グループ（シグマアルドリッチ社）、ポルファーマ・グループなどである。

ページTOPに戻る

1. Market Background

1.1 Scope and Product Outlook

1.2 Executive Summary

1.3 Research Methodology

2. Strategic Recommendations

2.1 Geographical expansion

2.2 Environmentally Sustainable Contract Manufacturing of HPAPI

3. Global HPAPI Contract Manufacturing Market: Historic and Forecast (2019-2029)

3.1 Age-standardised cancer incidence rate, 2020

3.2 Prevalence of Cancer

3.3 Competitive Landscape for Highly Potent Oncology Drugs in Pipeline

3.4 Global HPAPI Contract Manufacturing Market: Dashboard

3.5 Global HPAPI Contract Manufacturing Market: Market Value Assessment, 2019-2029 (USD Billion)

3.6 Impact of COVID-19 on Global HPAPI Contract Manufacturing Market

3.7 Global HPAPI Contract Manufacturing Market Segmentation: By Formulation

3.7.1 Global HPAPI Contract Manufacturing Market, By Formulation Overview

3.7.2 Global HPAPI Contract Manufacturing Market Size, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)

3.7.3 Global HPAPI Contract Manufacturing Market Size, By Oral Solids, By Value, 2019H-2029F (USD Billion & CAGR)

3.7.4 Global HPAPI Contract Manufacturing Market Size, By Lotions, By Value, 2019H-2029F (USD Billion & CAGR)

3.7.5 Global HPAPI Contract Manufacturing Market Size, By Other Formulations, By Value, 2019H-2029F (USD Billion & CAGR)

3.8 Global HPAPI Contract Manufacturing Market Segmentation: By End Use

3.8.1 Global HPAPI Contract Manufacturing Market, By End Use Overview

3.8.2 Global HPAPI Contract Manufacturing Market Size, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)

3.8.3 Global HPAPI Contract Manufacturing Market Size, By Antidiabetics, By Value, 2019H-2029F (USD Billion & CAGR)

3.8.4 Global HPAPI Contract Manufacturing Market Size, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)

3.8.5 Global HPAPI Contract Manufacturing Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)

4. Global HPAPI Contract Manufacturing Market, Regional Analysis

4.1 Regional Coverage of the Study

5. Americas HPAPI Contract Manufacturing Market: Historic and Forecast (2019-2029)

5.1 Americas HPAPI Contract Manufacturing Market: Snapshot

5.2 Americas HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

5.3 Americas HPAPI Contract Manufacturing Market: Key Factors

5.4 Americas HPAPI Contract Manufacturing Market Segmentation: By Formulation

5.4.1 Americas HPAPI Contract Manufacturing Market, By Formulation Overview

5.4.2 Americas HPAPI Contract Manufacturing Market Size, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)

5.4.3 Americas HPAPI Contract Manufacturing Market Size, By Oral Solids, By Value, 2019H-2029F (USD Billion & CAGR)

5.4.4 Americas HPAPI Contract Manufacturing Market Size, By Lotions, By Value, 2019H-2029F (USD Billion & CAGR)

5.4.5 Americas HPAPI Contract Manufacturing Market Size, By Other Formulations, By Value, 2019H-2029F (USD Billion & CAGR)

5.5 Americas HPAPI Contract Manufacturing Market Segmentation: By End Use

5.5.1 Americas HPAPI Contract Manufacturing Market, By End Use Overview

5.5.2 Americas HPAPI Contract Manufacturing Market Size, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)

5.5.3 Americas HPAPI Contract Manufacturing Market Size, By Antidiabetics, By Value, 2019H-2029F (USD Billion & CAGR)

5.5.4 Americas HPAPI Contract Manufacturing Market Size, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)

5.5.5 Americas HPAPI Contract Manufacturing Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)

5.6 Americas HPAPI Contract Manufacturing Market Segmentation: By Country

5.6.1 United States HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

5.6.1.1 United States HPAPI Contract Manufacturing Market, By Formulation

5.6.1.2 United States HPAPI Contract Manufacturing Market, By End Use

5.6.2 Canada HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

5.6.2.1 Canada HPAPI Contract Manufacturing Market, By Formulation

5.6.2.2 Canada HPAPI Contract Manufacturing Market, By End Use

5.6.3 Rest of Americas HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

5.6.3.1 Rest of Americas HPAPI Contract Manufacturing Market, By Formulation

5.6.3.2 Rest of Americas HPAPI Contract Manufacturing Market, By End Use

6. Europe HPAPI Contract Manufacturing Market: Historic and Forecast (2019-2029)

6.1 Europe HPAPI Contract Manufacturing Market: Snapshot

6.2 Europe HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

6.3 Europe HPAPI Contract Manufacturing Market: Key Factors

6.4 Europe HPAPI Contract Manufacturing Market Segmentation: By Formulation

6.4.1 Europe HPAPI Contract Manufacturing Market, By Formulation Overview

6.4.2 Europe HPAPI Contract Manufacturing Market Size, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)

6.4.3 Europe HPAPI Contract Manufacturing Market Size, By Oral Solids, By Value, 2019H-2029F (USD Billion & CAGR)

6.4.4 Europe HPAPI Contract Manufacturing Market Size, By Lotions, By Value, 2019H-2029F (USD Billion & CAGR)

6.4.5 Europe HPAPI Contract Manufacturing Market Size, By Other Formulations, By Value, 2019H-2029F (USD Billion & CAGR)

6.5 Europe HPAPI Contract Manufacturing Market Segmentation: By End Use

6.5.1 Europe HPAPI Contract Manufacturing Market, By End Use Overview

6.5.2 Europe HPAPI Contract Manufacturing Market Size, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)

6.5.3 Europe HPAPI Contract Manufacturing Market Size, By Antidiabetics, By Value, 2019H-2029F (USD Billion & CAGR)

6.5.4 Europe HPAPI Contract Manufacturing Market Size, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)

6.5.5 Europe HPAPI Contract Manufacturing Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)

6.6 Europe HPAPI Contract Manufacturing Market Segmentation: By Country

6.6.1 Germany HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

6.6.1.1 Germany HPAPI Contract Manufacturing Market, By Formulation

6.6.1.2 Germany HPAPI Contract Manufacturing Market, By End Use

6.6.2 Spain HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

6.6.2.1 Spain HPAPI Contract Manufacturing Market, By Formulation

6.6.2.2 Spain HPAPI Contract Manufacturing Market, By End Use

6.6.2 United Kingdom HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

6.6.2.1 United Kingdom HPAPI Contract Manufacturing Market, By Formulation

6.6.2.2 United Kingdom HPAPI Contract Manufacturing Market, By End Use

6.6.3 Switzerland HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

6.6.3.1 Switzerland HPAPI Contract Manufacturing Market, By Formulation

6.6.3.2 Switzerland HPAPI Contract Manufacturing Market, By End Use

6.6.4 Belgium HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

6.6.4.1 Belgium HPAPI Contract Manufacturing Market, By Formulation

6.6.4.2 Belgium HPAPI Contract Manufacturing Market, By End Use

6.6.5 Rest of Europe HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

6.6.5.1 Rest of Europe HPAPI Contract Manufacturing Market, By Formulation

6.6.5.2 Rest of Europe HPAPI Contract Manufacturing Market, By End Use

7. Asia-Pacific HPAPI Contract Manufacturing Market: Historic and Forecast (2019-2029)

7.1 Asia-Pacific HPAPI Contract Manufacturing Market: Snapshot

7.2 Asia-Pacific HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

7.3 Asia-Pacific HPAPI Contract Manufacturing Market: Key Factors

7.4 Asia-Pacific HPAPI Contract Manufacturing Market Segmentation: By Formulation

7.4.1 Asia-Pacific HPAPI Contract Manufacturing Market, By Formulation Overview

7.4.2 Asia-Pacific HPAPI Contract Manufacturing Market Size, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)

7.4.3 Asia-Pacific HPAPI Contract Manufacturing Market Size, By Oral Solids, By Value, 2019H-2029F (USD Billion & CAGR)

7.4.4 Asia-Pacific HPAPI Contract Manufacturing Market Size, By Lotions, By Value, 2019H-2029F (USD Billion & CAGR)

7.4.5 Asia-Pacific HPAPI Contract Manufacturing Market Size, By Other Formulations, By Value, 2019H-2029F (USD Billion & CAGR)

7.5 Asia-Pacific HPAPI Contract Manufacturing Market Segmentation: By End Use

7.5.1 Asia-Pacific HPAPI Contract Manufacturing Market, By End Use Overview

7.5.2 Asia-Pacific HPAPI Contract Manufacturing Market Size, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)

7.5.3 Asia-Pacific HPAPI Contract Manufacturing Market Size, By Antidiabetics, By Value, 2019H-2029F (USD Billion & CAGR)

7.5.4 Asia-Pacific HPAPI Contract Manufacturing Market Size, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)

7.5.5 Asia-Pacific HPAPI Contract Manufacturing Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)

7.6 Asia-Pacific HPAPI Contract Manufacturing Market Segmentation: By Country

7.6.1 China HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

7.6.1.1 China HPAPI Contract Manufacturing Market, By Formulation

7.6.1.2 China HPAPI Contract Manufacturing Market, By End Use

7.6.2 Japan HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

7.6.2.1 Japan HPAPI Contract Manufacturing Market, By Formulation

7.6.2.2 Japan HPAPI Contract Manufacturing Market, By End Use

7.6.3 India HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

7.6.3.1 India HPAPI Contract Manufacturing Market, By Formulation

7.6.3.2 India HPAPI Contract Manufacturing Market, By End Use

7.6.4 Rest of Asia-Pacific HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

7.6.4.1 Rest of Asia-Pacific HPAPI Contract Manufacturing Market, By Formulation

7.6.4.2 Rest of Asia-Pacific HPAPI Contract Manufacturing Market, By End Use

8. Middle-East & Africa HPAPI Contract Manufacturing Market: Historic and Forecast (2019-2029)

8.1 Middle-East & Africa HPAPI Contract Manufacturing Market: Snapshot

8.2 Middle-East & Africa HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

8.3 Middle-East & Africa HPAPI Contract Manufacturing Market: Key Factors

8.4 Middle-East & Africa HPAPI Contract Manufacturing Market Segmentation: By Formulation

8.4.1 Middle-East & Africa HPAPI Contract Manufacturing Market, By Formulation Overview

8.4.2 Middle-East & Africa HPAPI Contract Manufacturing Market Size, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)

8.4.3 Middle-East & Africa HPAPI Contract Manufacturing Market Size, By Oral Solids, By Value, 2019H-2029F (USD Billion & CAGR)

8.4.4 Middle-East & Africa HPAPI Contract Manufacturing Market Size, By Lotions, By Value, 2019H-2029F (USD Billion & CAGR)

8.4.5 Middle-East & Africa HPAPI Contract Manufacturing Market Size, By Other Formulations, By Value, 2019H-2029F (USD Billion & CAGR)

8.5 Middle-East & Africa HPAPI Contract Manufacturing Market Segmentation: By End Use

8.5.1 Middle-East & Africa HPAPI Contract Manufacturing Market, By End Use Overview

8.5.2 Middle-East & Africa HPAPI Contract Manufacturing Market Size, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)

8.5.3 Middle-East & Africa HPAPI Contract Manufacturing Market Size, By Antidiabetics, By Value, 2019H-2029F (USD Billion & CAGR)

8.5.4 Middle-East & Africa HPAPI Contract Manufacturing Market Size, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)

8.5.5 Middle-East & Africa HPAPI Contract Manufacturing Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)

9. Market Dynamics

9.1 Impact Assessment of Market Dynamics on the Global HPAPI Contract Manufacturing Market

9.2 Drivers

9.3 Restraints

9.4 Trends

10. Porter’s Five Forces Analysis

10.1 Porter’s Five Forces Model

11. Competitive Positioning

11.1 Companies’ Product Positioning

11.2 Market Position Matrix

11.3 Market Share Analysis of HPAPI Contract Manufacturing Market

11.4 Company Profiles

11.4.1 Lonza

11.4.2 Catalent, Inc.

11.4.3 Piramal Pharma Solutions

11.4.4 Pfizer CentreOne

11.4.5 Gentec Pharmaceutical Group

11.4.6 AbbVie Contract Manufacturing

11.4.7 Corden Pharma International

11.4.8 Curia Global, Inc.

11.4.9 Merck Group (SigmaAldrich Co., LLC)

11.4.10 Polpharma Group

ページTOPに戻る

Table of Contents

Summary

Executive Summary

Azoth Analytics has released a research report titled “High Potency API Contract Manufacturing Market (2023 Edition)” which provides a complete analysis of the global High Potency API Contract Manufacturing industry in terms of market segmentation by Formulation (Injectables, Oral Solids, Lotions, Other Formulations) and by End Use (Oncology, Antidiabetics, Autoimmune, Others) at the global, regional and country-level for the historical period of 2019-2022, the estimates of 2023 and the forecast period of 2024-2029.

The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, United Kingdom, Germany, Switzerland, Belgium, Spain, China, India, Japan). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast. The research study also assesses growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market's evolution.

The Global High Potency API Contract Manufacturing Market is expected to generate USD 21.12 billion by the end of 2029, up from USD 10.89 Billion in 2022. During the forecast period, 2024-2029, the Global High Potency API Contract Manufacturing market is expected to grow at a CAGR of 10.2%.

HPAPI contract manufacturing is a dynamic sector of the pharmaceutical industry specialising in the production of potent and complex therapeutic compounds. HPAPIs are distinguished by their substantial potency and low therapeutic quantities, often demanding careful handling as well as manufacturing procedures to guarantee both their safety and effectiveness.

Rising healthcare expenditures, particularly in developing nations, have been a key factor in the expansion of the contract manufacturing sector due to rising HPAPI demand among the local pharmaceutical companies looking to expand their product portfolio. Governments and the private sector are making investments in R&D and improving access to advanced therapies.

Additionally, a growing number of mid-scale pharmaceutical companies are also backing the market growth, as contract manufacturing enables them to produce such high-potency drugs without making large capital investments.

Scope of the Report:

• The report analyses the High Potency API Contract Manufacturing Market by Value (USD Billion).

• The report presents the analysis of the High Potency API Contract Manufacturing Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.

• The report analyses the High Potency API Contract Manufacturing Market by Formulation (Injectables, Oral Solids, Lotions Other Formulations).

• The report analyses the High Potency API Contract Manufacturing Market by End Use (Oncology, Antidiabetics, Autoimmune, Other End Uses).

• The key insights of the report have been presented through the frameworks of SWOT and Porter’s Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by services, by mode of operation & by end users.

• Also, the major opportunities, trends, drivers, and challenges of the industry have been analyzed in the report.

• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Lonza, Catalent, Inc., Piramal Pharma Solutions, Pfizer CentreOne, Gentec Pharmaceutical Group, AbbVie Contract Manufacturing, Corden Pharma International, Curia Global, Inc., Merck Group (SigmaAldrich Co., LLC) and Polpharma Group.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

本レポートと同分野の最新刊レポートはありません。

Azoth Analytics社の健康分野での最新刊レポート

本レポートと同じKEY WORD（contract）の最新刊レポート

よくあるご質問

Azoth Analytics社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

世界の高活性原薬（HPAPI）受託製造市場（2023年版）：製剤別（注射剤、経口固形剤、ローション、その他）、最終用途別、地域別、国別の分析：市場インサイトと予測（2019-2029年）

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野の最新刊レポート

Azoth Analytics社の健康分野での最新刊レポート

本レポートと同じKEY WORD（contract）の最新刊レポート

よくあるご質問

Azoth Analytics社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?